t cel

Allogene’s CAR-T ALLO-316 Demonstrates Ability to Produce Responses in Renal Cell Carcinoma, but Safety Data Includes 3 On-Study Deaths

CGTLive™ - 15 Nov 2024
Allogene’s CAR-T ALLO-316 Demonstrates Ability to Produce Responses in Renal Cell Carcinoma, but Safety Data Includes 3 On-Study Deaths ...

Early Serum IL-2 Levels Are Associated With CAR T-Cell Expansion Post–CAR T-Cell Therapy

OncLive - 11 Nov 2024
Early Serum IL-2 Levels Are Associated With CAR T-Cell Expansion Post–CAR T-Cell Therapy ...

Split-design approach enhances the therapeutic efficacy of ligand-based CAR-T cells against multiple B-cell malignancies

Nature.com - 11 Nov 2024
Split-design approach enhances the therapeutic efficacy of ligand-based CAR-T cells against multiple B-cell malignancies ...

Updated: FDA approves Autolus’ CAR-T cell therapy for aggressive blood cancer

Endpoints News - 11 Nov 2024
Updated: FDA approves Autolus’ CAR-T cell therapy for aggressive blood cancer ...

Adaptimmune nears second approval for TCR-T therapy

European Biotechnology News - 14 Nov 2024
Adaptimmune nears second approval for TCR-T therapy ...

Another TCR T-cell win as Adaptimmune focuses on rare sarcomas

BioWorld Online - 13 Nov 2024
Another TCR T-cell win as Adaptimmune focuses on rare sarcomas ...

Scottish medicines consortium approves CAR T-cell therapy for blood cancer

PharmaTimes - 11 Nov 2024
Scottish medicines consortium approves CAR T-cell therapy for blood cancer ...

FDA Approves Obe-cel for ALL

Medscape - 08 Nov 2024
FDA Approves Obe-cel for ALL ...

‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer

MedCity News - 10 Nov 2024
‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer ...

FDA Approves New CAR-T Therapy for Adults With Acute Leukemia

Cancer Health Treatment News - 14 Nov 2024
FDA Approves New CAR-T Therapy for Adults With Acute Leukemia ...

Some sarcoma patients improve with T cell immunotherapy – WashU Medicine

WashU Medicine - 05 Oct 2024
Some sarcoma patients improve with T cell immunotherapy – WashU Medicine ...

New CAR T-Cell Therapy Approved for Leukemia

Medpage Today - 08 Nov 2024
New CAR T-Cell Therapy Approved for Leukemia ...

Adaptimmune targets 2025 filing for lete-cel in rare sarcomas after Phase II win

FirstWord Pharma - 14 Nov 2024
Adaptimmune targets 2025 filing for lete-cel in rare sarcomas after Phase II win ...

Transposon-Based BAFF CAR T Cells Show Early Efficacy, Safety in R/R Non-Hodgkin Lymphoma

OncLive - 14 Nov 2024
Transposon-Based BAFF CAR T Cells Show Early Efficacy, Safety in R/R Non-Hodgkin Lymphoma ...

First Cancer TCR Cell Therapy Approved by FDA

NCI Cancer Bulletin - 27 Aug 2024
First Cancer TCR Cell Therapy Approved by FDA ...

Aggressive Lymphoma after CD19 CAR T-Cell Therapy

nejm.org - 02 Oct 2024
Aggressive Lymphoma after CD19 CAR T-Cell Therapy ...

Patient-reported outcomes of chimeric antigen receptor T-cell therapy in hematologic malignancies: a systematic review and meta-analysis

Nature.com - 28 Oct 2024
Patient-reported outcomes of chimeric antigen receptor T-cell therapy in hematologic malignancies: a systematic review and meta-analysis ...

Fixed-Dose CAR T Cells Followed by Escalating UB-TT170 Increases Cytokine Levels in R/R Osteosarcoma

OncLive - 11 Nov 2024
Fixed-Dose CAR T Cells Followed by Escalating UB-TT170 Increases Cytokine Levels in R/R Osteosarcoma ...

Dr Sborov on CAR T-Cell Therapy–Specific Long-Term Treatment Effects in Myeloma

OncLive - 11 Nov 2024
Dr Sborov on CAR T-Cell Therapy–Specific Long-Term Treatment Effects in Myeloma ...